Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer

Published:2022-06-17 Issue:2 Volume:7 Page:130-136
ISSN:2547-9431
Container-title:Bagcilar Medical Bulletin
language:
Short-container-title:BMB

Author:

Çavdar Eyyüp^ORCID,İriağaç Yakup^ORCID,Sakin Abdullah^ORCID,Şeber Erdoğan Selçuk^ORCID

Publisher

Galenos Yayinevi

Subject

General Medicine

Reference40 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dingemans;Ann Oncol,2021

3. A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511);Owonikoko;Lung Cancer,2015

4. 2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer;Zimmerman;J Thorac Oncol,2019

5. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: The COCIS meta-analysis of individual patient data;Rossi;J Clin Oncol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP